Top Abstract Purchase Related
Home
>
Node
>
Subnode

Effects of 6,6'-dithiodinicotinic acid (CPDS) and its metabolite 6-mercaptonicotinic acid (6-MNA) on murine and hamster fibroblasts (3T3 and BHK) and murine metastatic melanoma cells (F10)

D'Ancona, S.; Magnolfi, G.; Guidetti, G.; Toffoli, G.; Lazzarini, A.; Carrara, M.; Magon, M.; Luciani, S.; Berti, T.

Chemioterapia International Journal of the Mediterranean Society of ChemoTherapy 5(4): 219-227

1986

ISSN/ISBN: 0392-906X
PMID: 3769043
Document Number: 274270
We investigated the action of 6,6'-dithiodinicotinic acid (CPDS) and its metabolite 6-mercaptonicotinic acid (6-MNA) in vitro on murine (3T3) and baby hamster kidney (BHK) fibroblasts and an in vivo highly metastatic subline of murine B16 melanoma (F10). CPDS determined an inhibition of cell growth and a decrease in cell adhesion, while 6-MNA had no effect. When combined with data of the mitotic index and endogenous purine ribonucleotides (on which the drugs seem to have no effect), these observations are conceivable with the hypothesis that the primary target of CPDS is cell membrane.

Document emailed within 1 workday
Secure & encrypted payments

Kono, T.; Furukawa, M.; Tanii, T.; Taniguchi, S.; Mizuno, N.; Ishii, M.; Hamada, T. 1991: Effect of retinoic acid on the infiltration of murine melanoma cells into the type I collagen gel Acta Dermato-Venereologica 71(1): 41-44
Vistica, D.T.; Rabon, A.; Rabinovitz, M. 1979: Amino acid conferred protection against melphalan: comparison of amino acids which reduce melphalan toxicity to murine bone marrow precursor cells (CFU-C) and murine L1210 leukemia cells Research Communications in Chemical Pathology and Pharmacology 23(1): 171-183
Keyomarsi, K.; Moran, R.G. 1986: Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells Cancer Research 46(10): 5229-5235
Ikeda, T.; Murakami, K.; Sakukaw, R.; Hayakawa, Y.; Saiki, I. 2000: Characterization of a liver metastatic variant of murine K1735M2 melanoma cells In Vivo 14(4): 519-527
Weber, K.; Mengs, U.; Schwarz, T.; Hajto, T.; Hostanska, K.; Allen, T.R.; Weyhenmeyer, R.; Lentzen, H. 1998: Effects of a standardized mistletoe preparation on metastatic B16 melanoma colonization in murine lungs Arzneimittel-Forschung 48(5): 497-502
Aukerman, S.L.; Price, J.E.; Fidler, I.J. 1986: Different deficiencies in the prevention of tumorigenic-low-metastatic murine K-1735b melanoma cells from producing metastases Journal of the National Cancer Institute 77(4): 915-924
Baba, H.; Urano, T.; Okada, K.; Furukawa, K.; Nakayama, E.; Tanaka, H.; Iwasaki, K.; Shiku, H. 1995: Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line Cancer Research 55(9): 1977-1981
Gritli-Linde, A.; Björkman, U.; Delle, U.; Frostesjö, L.; Hultborn, R.; Hultén, K.; Johansson, B.R.; Nannmark, U.; Linde, A. 1998: Effects of suramin on polyamine metabolism in B16 murine melanoma cells Anticancer Research 18(2a): 855-862
Szary, J.; Missol, E.; Tarnawski, R.; Szala, S. 1997: Selective augmentation of radiation effects by 5-fluorocytosine on murine B16(F10) melanoma cells transfected with cytosine deaminase gene Cancer Gene Therapy 4(4): 269-272
Scanlon, K.J.; Safirstein, R.L.; Thies, H.; Gross, R.B.; Waxman, S.; Guttenplan, J.B. 1983: Inhibition of amino acid transport by cis-diamminedichloroplatinum(II) derivatives in L1210 murine leukemia cells Cancer Research 43(9): 4211-4215
Bogliolo, G.; Muzzulini, C.; Lerza, R.; Pannacciulli, I. 1986: Activity of doxorubicin linked to poly-L-aspartic acid on normal murine hematopoietic progenitor cells Cancer Treatment Reports 70(11): 1275-1281
Ho, C.-C.; Lin, S.-Y.; Yang, J.-S.; Liu, K.-C.; Tang, Y.-J.; Yang, M.-D.; Chiang, J.-H.; Lu, C.-C.; Wu, C.-L.; Chiu, T.-H.; Chung, J.-G. 2009: Gallic acid inhibits murine leukemia WEHI-3 cells in vivo and promotes macrophage phagocytosis In Vivo 23(3): 409-413
Guffy, M.M.; North, J.A.; Burns, C.P. 1984: Effect of cellular fatty acid alteration on adriamycin sensitivity in cultured L1210 murine leukemia cells Cancer Research 44(5): 1863-1866
Burns, C.P.; Luttenegger, D.G.; Dudley, D.T. 1980: Fatty acid alteration of L1210 murine leukemia cells. Growth rate and stability of lipid changes in culture Journal of the National Cancer Institute 65(5): 987-991
Sakiyama, H.; Nishino, Y.; Nishimura, K.; Noda, Y.; Otsu, H. 1984: Phagocytosis and solubilization of fixed cells by metastatic hamster embryo fibroblasts, Nil2C2 Cancer Research 44(5): 2023-2032
Tahara, H.; Zeh, H.J.; Storkus, W.J.; Pappo, I.; Watkins, S.C.; Gubler, U.; Wolf, S.F.; Robbins, P.D.; Lotze, M.T. 1994: Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo Cancer Research 54(1): 182-189
Watanabe, M.; Sugimoto, Y.; Tsuruo, T. 1990: Expression of a Mr 41,000 glycoprotein associated with thrombin-independent platelet aggregation in high metastatic variants of murine B16 melanoma Cancer Research 50(20): 6657-6662
Ziqing, D.; Yuqin, S.; Yue, Z.; Yin, L.; Han, G.; Haijiao, Y.; Chongtao, L. 2015: Effects of periodontitis patient's own tissue nucleic acid on the mRNA expression of osteoclast-related factors in murine macrophages Hua Xi Kou Qiang Yi Xue Za Zhi 33(2): 192-196
Elstad, C.A.; Meadows, G.G. 1993: Modulation of B16-BL6 murine melanoma metastatic phenotype by tyrosine and phenylalanine restriction in the absence of host selection pressures Anticancer Research 13(2): 523-528
Parratto, N.P.; Odebralski, J.M.; Kimura, A.K. 1989: Poorly metastatic tumor cell variants as primary targets of syngeneic antibody responses against murine melanoma Cancer Research 49(14): 3722-3728